Ramon R Quijano, MD | |
444 W Fort St., Fl 2, Boise, ID 83702-4535 | |
(208) 422-1018 | |
Not Available |
Full Name | Ramon R Quijano |
---|---|
Gender | Male |
Speciality | Psychiatry & Neurology - Addiction Psychiatry |
Location | 444 W Fort St., Boise, Idaho |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033341458 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | ME141651 (Florida) | Secondary |
2084P0802X | Psychiatry & Neurology - Addiction Psychiatry | ME141651 (Florida) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ramon R Quijano, MD 444 W Fort St., Crh 2nd Floor, Boise, ID 83702-4535 Ph: (208) 422-1018 | Ramon R Quijano, MD 444 W Fort St., Fl 2, Boise, ID 83702-4535 Ph: (208) 422-1018 |
News Archive
Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions affecting the aging spine, announced today the closing of its previously announced acquisition of Scient'x Groupe SAS, a spinal implant company headquartered in France.
The fine arts and the exact sciences may appear an unlikely pair, but creativity is a crucial element in both. Prof. Karen Avraham and PhD candidate Shaked Shivatzki of Tel Aviv University's Sackler Faculty of Medicine embraced this truth when creating Hearing and Deafness: Structure and Sequence, their winning submission to the recent American Society of Human Genetics art competition.
Rwanda next week will host the Conference on Social Health Protection in the East African Community, which "will consider various approaches to providing universal health coverage in Rwanda, Uganda, Kenya, Tanzania and Burundi," VOA News reports.
Patients with epilepsy are nearly eight times more likely than people without the condition to experience psychosis, show results of a systematic review and meta-analysis.
The anti-coagulant heparin reduces the likelihood of death from COVID-19 by 78% when administered in therapeutic doses to patients with signs of respiratory failure on admission to hospital, according to a study reported on October 14 in the British Medical Journal.
› Verified 9 days ago
Dr. Michael E. Estess, M. D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1471 Shoreline Dr, Suite 119, Boise, ID 83702 Phone: 208-345-2630 Fax: 208-345-6504 | |
John Carr, PMHNP Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1000 N Curtis Rd Ste 202, Boise, ID 83706 Phone: 208-283-7314 | |
Eric A Simmons, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 335 Allumbaugh St, Boise, ID 83704 Phone: 208-376-1611 Fax: 208-658-1753 | |
Dr. Gary Falk, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort St, Boise Vamc, Boise, ID 83702 Phone: 208-422-1108 | |
Karen Porth, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1072 N Liberty Street, Ste 303, Boise, ID 83704 Phone: 208-367-2800 Fax: 208-367-7111 | |
Barbara J. Hagen, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 413 Allumbaugh St Ste 101, Boise, ID 83704 Phone: 208-323-1125 Fax: 208-323-9604 |